The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Bayer; Boehringer Ingelheim; Lilly; Merck; Novartis; SERVIER
Research Funding - Amgen (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Celgene (Inst); Ipsen (Inst); Merck (Inst); Merck KGaA (Inst); Novartis (Inst); Roche (Inst); Sanofi (Inst)
Impact of overall severity of adverse events (AEs) on long-term outcomes in metastatic colorectal cancer (mCRC) patients (pts) treated with first line systemic chemotherapy: Findings from 3,971 pts in the ARCAD database.
 
John Raymond Zalcberg
Honoraria - Amgen; Bayer; Merck Serono; Pfizer; Roche; Specialised Therapeutics
Consulting or Advisory Role - Amgen; Bayer; Merck Serono; Pfizer; Roche; Specialised Therapeutics
Research Funding - Amgen (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Merck Serono (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Shire (Inst)
Travel, Accommodations, Expenses - Ipsen; Merck Serono
 
Qian Shi
No Relationships to Disclose
 
Danielle Angela Ferraro
Research Funding - Merck Serono
Travel, Accommodations, Expenses - AstraZeneca
 
Jeffrey P. Meyers
No Relationships to Disclose
 
Leonard Saltz
Consulting or Advisory Role - Abbvie; Lilly; McNeil PPC (I)
Research Funding - Taiho Pharmaceutical
 
Richard Goldberg
No Relationships to Disclose
 
Eric Van Cutsem
No Relationships to Disclose
 
Herbert Hurwitz
Honoraria - Genentech/Roche; Lilly/ImClone
Consulting or Advisory Role - Acceleron Pharma; Bristol-Myers Squibb; Genentech/Roche; GlaxoSmithKline; Incyte; Lilly; Novartis; OncoMed; TRACON Pharma
Research Funding - Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Lilly (Inst); Macrogenics (Inst); NCI (Inst); Novartis (Inst); Regeneron (Inst); TRACON Pharma (Inst)
 
Charles Fuchs
No Relationships to Disclose
 
Carsten Bokemeyer
Honoraria - Bayer; Bristol-Myers Squibb; Merck KGaA; Roche; Sanofi
Consulting or Advisory Role - Bayer Schering Pharma; Hexal; Lilly/ImClone; Merck Serono; Mundipharma; Sanofi
Travel, Accommodations, Expenses - Merck Serono; Sanofi
 
Daniel J. Sargent
Consulting or Advisory Role - Abbvie; Acerta Pharma; ARIAD; Astellas Pharma; AstraZeneca/MedImmune; Biothera; Celldex; Exelixis; Genentech; Incyte; Kyowa Hakko Kirin; Medivation; Merck; Merrimack; Nektar; Novartis; Pharmacyclics; Pique; Spiration; Xbiotech
Research Funding - Celgene (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Celgene
 
Aimery De Gramont
Honoraria - Roche
Travel, Accommodations, Expenses - Sanofi
 
Timothy Jay Price
Consulting or Advisory Role - Amgen (Inst); Merck Serono (Inst); Roche (Inst)
 
Richard Adams
Honoraria - Merck
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Merck
Speakers' Bureau - Merck
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Merck